Parkinson hastalığı için derinlemesine metabolomik analiz kullanarak yeni metabolik biyobelirteçler üretmek.
Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
DOI: 10.1002/mds.27173PMID: 28880465
“Parkinson meta analysis” Aramayı temizle
Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
DOI: 10.1002/mds.27173PMID: 28880465
Endurance exercise improves function in individuals with Parkinson's disease: A meta-analysis.
DOI: 10.1016/j.neulet.2017.08.076PMID: 28870627
Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
DOI: 10.1016/j.neulet.2017.08.051PMID: 28844730
Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.
DOI: 10.1159/000479555PMID: 28813703
Changes of cerebrospinal fluid Aβ<sub>42</sub>, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.
DOI: 10.1007/s10072-017-3088-1PMID: 28808876
Association between PARK16 and Parkinson's disease: A meta-analysis.
DOI: 10.1016/j.neulet.2017.08.022PMID: 28807727
Effectiveness and safety of acupuncture in the treatment of Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.
DOI: 10.1016/j.ctim.2017.08.005PMID: 28917379
Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples.
DOI: 10.1159/000477165PMID: 28746937
Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.
DOI: 10.1016/j.bbr.2017.07.025PMID: 28743601
Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis.
DOI: 10.1016/j.nicl.2017.07.011PMID: 28765809
Procedural learning in Parkinson's disease, specific language impairment, dyslexia, schizophrenia, developmental coordination disorder, and autism spectrum disorders: A second-order meta-analysis.
DOI: 10.1016/j.bandc.2017.07.004PMID: 28710941
Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effects.
DOI: 10.1038/s41531-017-0024-2PMID: 28702504
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.